Complete Up To Date Information about Neomix 325 Medicated Premix.
NADA Number: 140-976 | |
| Proprietary Name |
Neomix® 325 Medicated Premix Neomix® 325 Milk Replacer Neomix® AG 325 Milk Replacer Neomix® AG 325 Medicated Premix |
|---|---|
| Sponsor |
Pharmacia & Upjohn Co. |
| Sponsor Address |
a Division of Pfizer, Inc. 235 East 42nd St. New York, NY 10017 USA |
| Ingredients |
Neomycin Sulfate |
| Species |
Cattle, beef Goats, excluding lactating or females over 12 months of age Cattle, dairy, females under 20 months of age Cattle, calves, excluding veal calves Sheep, no use class stated or implied Swine, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Medicated feed |
| Drug Form |
Type A Medicated Article |
| Dispensing Status |
OTC |
| Withdrawal Time |
Cattle: 1 day before slaughter. A withdrawal time for pre-ruminating veal calves has not been established.
Sheep: 2 day before slaughter.
Swine: 3 days before slaughter.
Goats: 3 days before slaughter. |
|
Dosage Amount, Indications & Limitations |
558.364 Neomycin sulfate. Specifications: Type A medicated article 325 grams per pound Conditions of use: Cattle Amount: Type C milk replacer 400 to 2,000 grams per ton. Indications: For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Limitations: To provide 10 milligrams of neomycin sulfate per pound of body weight for a maximum of 14 days. Amount consumed will vary depending on animal's consumption and weight. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter 1 day. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle or lactating dairy goats. Do not use in female dairy cattle 20 months of age or older or female dairy goats 12 months of age or older. For use in dry feeds only. Not for use in liquid feed supplements. For milk replacers only. Amount: Type C feed 250 to 2,500 grams per ton. Indications: For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Limitations: To provide 10 mg of neomycin sulfate per pound of body weight per day for a maximum of 14 days. The concentration of neomycin sulfate required in medicated feed must be adjusted to compensate for variation in age and weight of animal, the nature and severity of disease signs, and environmental temperature and humidity, each of which affects feed consumption. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter as follows: Cattle 1 day, swine 3 days, sheep 2 days, goats 3 days. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle or lactating dairy goats. Do not use in female dairy cattle 20 months of age or older or female dairy goats 12 months of age or older. For use in dry feeds only. Not for use in liquid feed supplements. Swine Amount: Type C milk replacer 400 to 2,000 grams per ton. Indications: For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Limitations: To provide 10 milligrams of neomycin sulfate per pound of body weight for a maximum of 14 days. Amount consumed will vary depending on animal's consumption and weight. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter 3 days. Not for use in liquid feed supplements. For milk replacers only. Amount: Type C feed 250 to 2,500 grams per ton. Indications: For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Limitations: To provide 10 mg of neomycin sulfate per pound of body weight per day for a maximum of 14 days. The concentration of neomycin sulfate required in medicated feed must be adjusted to compensate for variation in age and weight of animal, the nature and severity of disease signs, and environmental temperature and humidity, each of which affects feed consumption. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter 3 days. Not for use in liquid feed supplements. Sheep Amount: Type C milk replacer 400 to 2,000 grams per ton. Indications: For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Limitations: To provide 10 milligrams of neomycin sulfate per pound of body weight for a maximum of 14 days. Amount consumed will vary depending on animal's consumption and weight. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter 2 days. Not for use in liquid feed supplements. For milk replacers only. Amount: Type C feed 250 to 2,500 grams per ton. Indications: For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Limitations: To provide 10 mg of neomycin sulfate per pound of body weight per day for a maximum of 14 days. The concentration of neomycin sulfate required in medicated feed must be adjusted to compensate for variation in age and weight of animal, the nature and severity of disease signs, and environmental temperature and humidity, each of which affects feed consumption. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter 2 days. Not for use in liquid feed supplements. Goats Amount: Type C milk replacer 400 to 2,000 grams per ton. Indications: For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Limitations: To provide 10 milligrams of neomycin sulfate per pound of body weight for a maximum of 14 days. Amount consumed will vary depending on animal's consumption and weight. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter 3 days. Do not use in female dairy goats 12 months of age or older. Not for use in liquid feed supplements. For milk replacers only. Amount: Type C feed 250 to 2,500 grams per ton. Indications: For treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Limitations: To provide 10 mg of neomycin sulfate per pound of body weight per day for a maximum of 14 days. The concentration of neomycin sulfate required in medicated feed must be adjusted to compensate for variation in age and weight of animal, the nature and severity of disease signs, and environmental temperature and humidity, each of which affects feed consumption. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Do not use in female dairy goats 12 months of age or older. Discontinue treatment prior to slaughter 3 days. Not for use in liquid feed supplements. |
| Tolerances |
Tolerances are established for residues of parent neomycin in uncooked edible tissues as follows: a. In cattle, swine, sheep, and goats: 7.2 parts per million in kidney (target tissue) and fat, 3.6 ppm in liver, and 1.2 ppm in muscle. b. In turkeys: 7.2 ppm in skin with adhering fat, 3.6 parts per million in liver, and 1.2 ppm in muscle. c. In milk: 0.15 part per million. |